메뉴 건너뛰기




Volumn 9, Issue 2, 2013, Pages 106-112

Current therapies in rheumatoid arthritis: A Latin American perspective

Author keywords

Biologic therapy; Latin America; Practice guidelines; Rheumatoid arthritis; Socioeconomic factors

Indexed keywords

ABATACEPT; ADALIMUMAB; AZATHIOPRINE; BIOSIMILAR AGENT; CERTOLIZUMAB PEGOL; CHLOROQUINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANAR; ETANERCEPT; FOSTAMATINIB; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TOFACITINIB; UNCLASSIFIED DRUG;

EID: 84875380431     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2012.09.001     Document Type: Short Survey
Times cited : (46)

References (57)
  • 1
    • 77956055481 scopus 로고    scopus 로고
    • Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
    • Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581.
    • (2010) Arthritis Rheum , vol.62 , pp. 2569-2581
    • Aletaha, D.1    Neogi, T.2    Silman, A.J.3    Funovits, J.4    Felson, D.T.5    Bingham, C.O.6
  • 3
    • 84891661327 scopus 로고    scopus 로고
    • Health care utilization and direct medical costs in patients with rheumatoid arthritis in a developing country
    • Soriano E.R., Castel del Cid C., Devoto F., Imamura P., Catoggio L. Health care utilization and direct medical costs in patients with rheumatoid arthritis in a developing country. Rheumatology 2005, 44:i54.
    • (2005) Rheumatology , vol.44
    • Soriano, E.R.1    Castel del Cid, C.2    Devoto, F.3    Imamura, P.4    Catoggio, L.5
  • 4
    • 78049287592 scopus 로고    scopus 로고
    • The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city in Buenos Aires province
    • Scublinsky D., Venarotti H., Citera G., Messina O.D., Scheines E., Rillo O., et al. The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city in Buenos Aires province. J Clin Rheumatol 2010, 16:317-321.
    • (2010) J Clin Rheumatol , vol.16 , pp. 317-321
    • Scublinsky, D.1    Venarotti, H.2    Citera, G.3    Messina, O.D.4    Scheines, E.5    Rillo, O.6
  • 6
    • 0036708856 scopus 로고    scopus 로고
    • Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study
    • Cardiel M.H., Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheum 2002, 20:617-662.
    • (2002) Clin Exp Rheum , vol.20 , pp. 617-662
    • Cardiel, M.H.1    Rojas-Serrano, J.2
  • 8
    • 50849109500 scopus 로고    scopus 로고
    • Challenges in the management of rheumatoid arthritis in developing countries
    • Mody G.M., Cardiel M.H. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol 2008, 22:621-641.
    • (2008) Best Pract Res Clin Rheumatol , vol.22 , pp. 621-641
    • Mody, G.M.1    Cardiel, M.H.2
  • 9
    • 84875374191 scopus 로고    scopus 로고
    • Bloomberg School of Public Health, Johns Hopkins University. Non-communicable chronic diseases in Latin America and the Caribbean. The Healthy Caribbean Coalition Website: [accessed 13.11.11].
    • Bloomberg School of Public Health, Johns Hopkins University. Non-communicable chronic diseases in Latin America and the Caribbean. The Healthy Caribbean Coalition Website: [accessed 13.11.11]. http://www.healthycaribbean.org/publications/documents/NCD-in-LAC-USAID.pdf.
  • 10
    • 79955631079 scopus 로고    scopus 로고
    • The burden of illness of rheumatoid arthritis
    • Boonen A., Severens J.L. The burden of illness of rheumatoid arthritis. Clin Rheumatol 2011, 30:S3-S8.
    • (2011) Clin Rheumatol , vol.30
    • Boonen, A.1    Severens, J.L.2
  • 14
    • 0034062017 scopus 로고    scopus 로고
    • The costs of rheumatoid arthritis: an international long-term view
    • Pugner K.M., Scott D.I., Holmes J.W., Hieke K. The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum 2000, 29:305-320.
    • (2000) Semin Arthritis Rheum , vol.29 , pp. 305-320
    • Pugner, K.M.1    Scott, D.I.2    Holmes, J.W.3    Hieke, K.4
  • 15
  • 17
    • 38449083553 scopus 로고    scopus 로고
    • The burden of rheumatoid arthritis and access to treatment: health burden and costs
    • Lundkvist J., Kastäng F., Kobelt G. The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 2008, 8:S49-S60.
    • (2008) Eur J Health Econ , vol.8
    • Lundkvist, J.1    Kastäng, F.2    Kobelt, G.3
  • 18
    • 68049127280 scopus 로고    scopus 로고
    • Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database
    • Sokka T., Kautiainen H., Pincus T., Toloza S., da Rocha Castelar Pinheiro G., Lazovskis J., et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009, 68:1666-1672.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1666-1672
    • Sokka, T.1    Kautiainen, H.2    Pincus, T.3    Toloza, S.4    da Rocha Castelar Pinheiro, G.5    Lazovskis, J.6
  • 19
    • 33747044702 scopus 로고    scopus 로고
    • First Latin American position paper on the pharmacological treatment of rheumatoid arthritis
    • Cardiel M.H. First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:ii7-ii22.
    • (2006) Rheumatology (Oxford) , vol.45
    • Cardiel, M.H.1
  • 20
    • 67650930350 scopus 로고    scopus 로고
    • Management of patients with rheumatoid arthritis in Latin America. A Consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano de Estudio de Artritis Reumatoide
    • Massardo L., Suarez-Almazor M.E., Cardiel M.H., Nava A., Levy R.A., Laurindo I., et al. Management of patients with rheumatoid arthritis in Latin America. A Consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano de Estudio de Artritis Reumatoide. J Clin Rheumatol 2009, 15:203-210.
    • (2009) J Clin Rheumatol , vol.15 , pp. 203-210
    • Massardo, L.1    Suarez-Almazor, M.E.2    Cardiel, M.H.3    Nava, A.4    Levy, R.A.5    Laurindo, I.6
  • 22
    • 84875374912 scopus 로고    scopus 로고
    • Sociedad Argentina de Reumatología. Guías argentinas de práctica clínica en el tratamiento de la artritis reumatoide: Actualización. Revista Argentina de Reumatología. [accessed 04.04.12].
    • Sociedad Argentina de Reumatología. Guías argentinas de práctica clínica en el tratamiento de la artritis reumatoide: Actualización. Revista Argentina de Reumatología. [accessed 04.04.12]. http://www.reumatologia.org.ar/userfiles/file/publicaciones/revista-reumatologia/SAR_GuiasTCZ_2011.pdf.
  • 24
    • 79955537882 scopus 로고    scopus 로고
    • Ministerio de Salud, MINSAL, Santiago, [accessed 04.04.12]
    • Guía Clínica Artritis Reumatoidea 2007, Ministerio de Salud, MINSAL, Santiago, [accessed 04.04.12]. http://www.redsalud.gov.cl/archivos/guiasges/artritispdf.pdf.
    • (2007) Guía Clínica Artritis Reumatoidea
  • 25
    • 84875373209 scopus 로고    scopus 로고
    • Asociación Colombiana de Reumatología, Exlibris Editores SA, DC Bogota, [accessed 04.04.12]
    • Guías para el tratamiento de la artritis reumatoide 2002, Asociación Colombiana de Reumatología, Exlibris Editores SA, DC Bogota, [accessed 04.04.12]. http://dnn.asoreuma.org/Portals/0/Descargas/GUIA%20PARA%20EL%20TRATAMIENTO%20DE%20LA%20AR%20Parte%201.pdf.
    • (2002) Guías para el tratamiento de la artritis reumatoide
  • 26
    • 84891664189 scopus 로고    scopus 로고
    • Costa Rican Association of Rheumatology Guías de manejo de la artritis reumatoide Concenso 2010
    • Costa Rican Association of Rheumatology Guías de manejo de la artritis reumatoide Concenso 2010. Acta Med Costarric 2011, 53:19-25.
    • (2011) Acta Med Costarric , vol.53 , pp. 19-25
  • 27
    • 33646554170 scopus 로고    scopus 로고
    • Colegio Mexicano de Reumatología. Guías y recomendaciones del Colegio Mexicano de Reumatología para el uso de agentes biológicos en enfermos reumáticos
    • Comité Mexicano del Consenso de Biológicos
    • Colegio Mexicano de Reumatología. Guías y recomendaciones del Colegio Mexicano de Reumatología para el uso de agentes biológicos en enfermos reumáticos. Reumatol Clin 2006, 2:78-89. Comité Mexicano del Consenso de Biológicos.
    • (2006) Reumatol Clin , vol.2 , pp. 78-89
  • 28
    • 84875373651 scopus 로고    scopus 로고
    • Instituto Mexicano del Seguro Social. Guia de Referencia Rapida: Diagnostico y Tratamiento de Artritis Rheumatoide del Adulto. IMSS Website: [accessed 04.04.12].
    • Instituto Mexicano del Seguro Social. Guia de Referencia Rapida: Diagnostico y Tratamiento de Artritis Rheumatoide del Adulto. IMSS Website: [accessed 04.04.12]. http://www.cvsp.cucs.udg.mx/guias/TODAS/IMSS_195_08_ARTRITIS_REUMATOIDE/IMSS_195_08_GRR.pdf.
  • 29
    • 69949168726 scopus 로고    scopus 로고
    • Very recent onset arthritis: the value of initial rheumatologist and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis
    • Rojas-Serrano J., Burgos-Vargas R., Lino Perez L., García C.G., Moctezuma F., Vázquez-Mellado J. Very recent onset arthritis: the value of initial rheumatologist and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Rheumatol 2009, 28:1135-1139.
    • (2009) Clin Rheumatol , vol.28 , pp. 1135-1139
    • Rojas-Serrano, J.1    Burgos-Vargas, R.2    Lino Perez, L.3    García, C.G.4    Moctezuma, F.5    Vázquez-Mellado, J.6
  • 30
    • 3242677099 scopus 로고    scopus 로고
    • Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
    • Grigor C., Capell H., Stirling A., McMahon A.D., Lock P., Vallance R., et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004, 364:263-269.
    • (2004) Lancet , vol.364 , pp. 263-269
    • Grigor, C.1    Capell, H.2    Stirling, A.3    McMahon, A.D.4    Lock, P.5    Vallance, R.6
  • 31
    • 79952362560 scopus 로고    scopus 로고
    • Disease activity score-driven therapy versus routine care in patients with recent onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort
    • Soubrier M., Lukas C., Sibilia J., Fautrel B., Roux F., Gossec L., et al. Disease activity score-driven therapy versus routine care in patients with recent onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis 2011, 70:611-615.
    • (2011) Ann Rheum Dis , vol.70 , pp. 611-615
    • Soubrier, M.1    Lukas, C.2    Sibilia, J.3    Fautrel, B.4    Roux, F.5    Gossec, L.6
  • 32
  • 33
    • 33846001961 scopus 로고    scopus 로고
    • EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    • Combe B., Landewe R., Lukas C., Bolosiu H.D., Breedveld F., Dougados M., et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007, 66:34-45.
    • (2007) Ann Rheum Dis , vol.66 , pp. 34-45
    • Combe, B.1    Landewe, R.2    Lukas, C.3    Bolosiu, H.D.4    Breedveld, F.5    Dougados, M.6
  • 34
    • 84875375113 scopus 로고    scopus 로고
    • Registro Panamericano de acontecimientos adversos de terapias biológicas en enfermedades reumáticas. BIOBADASER Website: [accessed 07.11.11].
    • Registro Panamericano de acontecimientos adversos de terapias biológicas en enfermedades reumáticas. BIOBADASER Website: [accessed 07.11.11]. https://biobadaser.ser.es/biobadamerica/.
  • 35
    • 48149100741 scopus 로고    scopus 로고
    • Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial
    • Emery P., Breedveld F.C., Hall S., Durez P., Chang D.J., Robertson D., et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial. Lancet 2008, 372:375-382.
    • (2008) Lancet , vol.372 , pp. 375-382
    • Emery, P.1    Breedveld, F.C.2    Hall, S.3    Durez, P.4    Chang, D.J.5    Robertson, D.6
  • 37
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • Breedveld F.C., Weisman M.H., Kavanaugh A.F., Cohen S.B., Pavelka K., van Vollenhoven R., et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006, 54:26-37.
    • (2006) Arthritis Rheum , vol.54 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3    Cohen, S.B.4    Pavelka, K.5    van Vollenhoven, R.6
  • 38
    • 79953711736 scopus 로고    scopus 로고
    • B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study
    • Sellam J., Hendel-Chavez H., Rouanet S., Abbed K., Combe B., Le Loët X., et al. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study. Arthritis Rheum 2011, 63:933-938.
    • (2011) Arthritis Rheum , vol.63 , pp. 933-938
    • Sellam, J.1    Hendel-Chavez, H.2    Rouanet, S.3    Abbed, K.4    Combe, B.5    Le Loët, X.6
  • 39
    • 24944498854 scopus 로고    scopus 로고
    • Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition [published correction appears in N Engl J Med 2005;353:2311]
    • Genovese M.C., Becker J.C., Schiff M., Luggen M., Sherrer Y., Kremer J., et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition [published correction appears in N Engl J Med 2005;353:2311]. N Engl J Med 2005, 353:1114-1123.
    • (2005) N Engl J Med , vol.353 , pp. 1114-1123
    • Genovese, M.C.1    Becker, J.C.2    Schiff, M.3    Luggen, M.4    Sherrer, Y.5    Kremer, J.6
  • 40
    • 52149099504 scopus 로고    scopus 로고
    • IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial [published correction appears in Ann Rheum Dis 2009;68:296]
    • Emery P., Keystone E., Tony H.P., Cantagre A., van Vollenhoven R., Sanchez A., et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial [published correction appears in Ann Rheum Dis 2009;68:296]. Ann Rheum Dis 2008, 67:1516-1523.
    • (2008) Ann Rheum Dis , vol.67 , pp. 1516-1523
    • Emery, P.1    Keystone, E.2    Tony, H.P.3    Cantagre, A.4    van Vollenhoven, R.5    Sanchez, A.6
  • 41
    • 53649101010 scopus 로고    scopus 로고
    • Emerging therapeutics for rheumatoid arthritis
    • Bingham C.O. Emerging therapeutics for rheumatoid arthritis. Bull NYU Hosp Jt Dis 2008, 66:210-215.
    • (2008) Bull NYU Hosp Jt Dis , vol.66 , pp. 210-215
    • Bingham, C.O.1
  • 42
    • 77955339521 scopus 로고    scopus 로고
    • New and emerging therapies for the treatment of rheumatoid arthritis
    • Feely M.G. New and emerging therapies for the treatment of rheumatoid arthritis. Open Access Rheumatol Res Rev 2010, 2:35-43.
    • (2010) Open Access Rheumatol Res Rev , vol.2 , pp. 35-43
    • Feely, M.G.1
  • 43
    • 84862272498 scopus 로고    scopus 로고
    • Tofacitinib (CP-690,550), an oral janus kinase inhibitor, or adalimumab versus placebo in patients with rheumatoid arthritis on background methotrexate: a phase 3 study
    • van Vollenhoven R., Fleischmann R., Cohen S., Lee E.B., Meijide G., Wagner S., et al. Tofacitinib (CP-690,550), an oral janus kinase inhibitor, or adalimumab versus placebo in patients with rheumatoid arthritis on background methotrexate: a phase 3 study. Arthritis Rheum 2011, 63:S153.
    • (2011) Arthritis Rheum , vol.63
    • van Vollenhoven, R.1    Fleischmann, R.2    Cohen, S.3    Lee, E.B.4    Meijide, G.5    Wagner, S.6
  • 45
    • 67650379733 scopus 로고    scopus 로고
    • Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicenter, randomized, double-blind, placebo-controlled, phase III trial
    • Smolen J.S., Kay J., Doyle M.K., Landewé R., Matteson E.L., Wollenhaupt J., et al. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicenter, randomized, double-blind, placebo-controlled, phase III trial. Lancet 2009, 374:210-221.
    • (2009) Lancet , vol.374 , pp. 210-221
    • Smolen, J.S.1    Kay, J.2    Doyle, M.K.3    Landewé, R.4    Matteson, E.L.5    Wollenhaupt, J.6
  • 46
    • 67449124634 scopus 로고    scopus 로고
    • Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomized, controlled trial
    • Smolen J., Landewe R.B., Mease P., Brzezicki J., Mason D., Luijtens K., et al. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomized, controlled trial. Ann Rheum Dis 2009, 68:797-804.
    • (2009) Ann Rheum Dis , vol.68 , pp. 797-804
    • Smolen, J.1    Landewe, R.B.2    Mease, P.3    Brzezicki, J.4    Mason, D.5    Luijtens, K.6
  • 47
    • 80053469218 scopus 로고    scopus 로고
    • Biosimilars: the debate continues
    • Colbert R.A., Cronstein B.N. Biosimilars: the debate continues. Arthritis Rheum 2011, 63:2848-2850.
    • (2011) Arthritis Rheum , vol.63 , pp. 2848-2850
    • Colbert, R.A.1    Cronstein, B.N.2
  • 48
    • 39549105384 scopus 로고    scopus 로고
    • Scientific and legal viability of follow-on protein drugs
    • Dudzinski D.M., Kesselheim A.S. Scientific and legal viability of follow-on protein drugs. N Engl J Med 2008, 358:843-849.
    • (2008) N Engl J Med , vol.358 , pp. 843-849
    • Dudzinski, D.M.1    Kesselheim, A.S.2
  • 49
    • 82155188444 scopus 로고    scopus 로고
    • Biosimilars: a regulatory perspective from America
    • Kay J. Biosimilars: a regulatory perspective from America. Arthritis Res Ther 2011, 13:112.
    • (2011) Arthritis Res Ther , vol.13 , pp. 112
    • Kay, J.1
  • 50
    • 80051984166 scopus 로고    scopus 로고
    • Biosimilars of biological drugs therapies, regulatory, clinical and commercial considerations
    • Dranitsaris G., Amir E., Dorward K. Biosimilars of biological drugs therapies, regulatory, clinical and commercial considerations. Drugs 2011, 71:1527-1536.
    • (2011) Drugs , vol.71 , pp. 1527-1536
    • Dranitsaris, G.1    Amir, E.2    Dorward, K.3
  • 51
    • 84887909791 scopus 로고    scopus 로고
    • Mexico recovers leadership on regulation of biosimilar biotech drugs
    • López-Silva C. Mexico recovers leadership on regulation of biosimilar biotech drugs. Gac Med Mex 2012, 148:83-90.
    • (2012) Gac Med Mex , vol.148 , pp. 83-90
    • López-Silva, C.1
  • 52
    • 80055096139 scopus 로고    scopus 로고
    • Etanar therapy in real-life patients with rheumatoid arthritis
    • [abstract]
    • Rondon F., Bautista A., Salazar J.C., Casas N., Santos P., Vargas F., et al. Etanar therapy in real-life patients with rheumatoid arthritis. Arthritis Rheum 2010, 62(Suppl. 10):1811. [abstract].
    • (2010) Arthritis Rheum , vol.62 , Issue.SUPPL. 10 , pp. 1811
    • Rondon, F.1    Bautista, A.2    Salazar, J.C.3    Casas, N.4    Santos, P.5    Vargas, F.6
  • 53
    • 84875376104 scopus 로고    scopus 로고
    • Dr Reddy's brand of rituximab. Dr Reddy's Laboratories Inc. Website: [accessed 04.04.12].
    • Dr Reddy's brand of rituximab. Dr Reddy's Laboratories Inc. Website: [accessed 04.04.12]. http://www.drreddys.com/products/pdf/bio/Reditux-splash.pdf.
  • 54
    • 84875378513 scopus 로고    scopus 로고
    • TL011 in Severe, Active Rheumatoid Arthritis Patients. Clinical Trials Website: Accessed February 7
    • TL011 in Severe, Active Rheumatoid Arthritis Patients. Clinical Trials Website: Accessed February 7, 2012. http://www.clinicaltrials.gov/ct2/show/NCT01123070%3Fterm=TEVA%26cond=arthritis%26rank=2.
    • (2012)
  • 55
    • 84875376167 scopus 로고    scopus 로고
    • Yisaipu Website: [accessed 22.08.12].
    • Yisaipu Website: [accessed 22.08.12]. http://www.yisaipu.com/DiseaseList.aspx%3Fcate_id=20%26topCateID1=20%26topCateID=15.
  • 56
    • 84875379103 scopus 로고    scopus 로고
    • PRX-106. Protalix Biotherapeutics Website: [accessed 04.04.12].
    • PRX-106. Protalix Biotherapeutics Website: [accessed 04.04.12]. http://www.protalix.com/product-development/prx-106.asp.
  • 57
    • 84875379073 scopus 로고    scopus 로고
    • Pipelines. LG Life Sciences Website: [accessed 04.04.12].
    • Pipelines. LG Life Sciences Website: [accessed 04.04.12]. http://www.lgls.com/rd/pipeline.jsp.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.